They may thereby respond to the same treatment, as suggested by a recent report on the benefit from procarbazine, lomustine, and vincristine treatment in IDH-mutant oligodendrogliomas irrespective of 1p19q co-deletion status [84]. Here, IDH1 is linked to oligodendroglioma.